Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · TuHURA Biosciences, Inc./NV (HURA)

TuHURA Biosciences draws additional $650,000 under Parkview revolving credit facility

Neutral Impact 2 of 5 financing Written later

TuHURA Biosciences borrowed an additional $650,000 under a revolving credit facility with Parkview Holdings One LLC on September 14, 2026, which it expects to use for general corporate purposes. The facility has a maximum availability of $50 million and matures on April 21, 2031, so the draw adds a small amount of debt against that capacity.

Key points

  • Draw of $650,000 received and borrowed on September 14, 2026 under the revolving credit facility
  • Loan Agreement with Parkview Holdings One LLC dated April 21, 2026, with maximum loan availability of $50 million
  • Facility matures April 21, 2031; filing notes lender is an affiliate of the company's largest stockholder

The filing

CompanyTuHURA Biosciences, Inc./NV (HURA)
Form8-K, current report
Filed with the SECSep 17, 2026, 5:00 PM ET
Accession number0001193125-26-394473

Items reported: 2.03 New Direct Financial Obligation

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 17, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.